Tirzepatide is a 39amino acid dual incretin receptor agonist that activates both GLP1 and GIP receptors, enhancing glucosedependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2]
Where to start if you have never run it: half the standard dose, one 50 mg vial per 20 days
This provides fat loss benefits plus additional effects like improved sleep, recovery, and muscle growth
This is particularly relevant for plantar fasciitis, as the condition often involves inflammation at the calcaneal attachment point where the fascia connects to the heel bone
Additionally, growing interest in personalized medicine and data-driven healthcare is encouraging the use of observational research to capture lifestyle, genetic, and environmental factors influencing obesity